Holter-monitor
发表于 2025-3-21 16:26:24
书目名称Bone Drugs in Pediatrics影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0189665<br><br> <br><br>书目名称Bone Drugs in Pediatrics影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0189665<br><br> <br><br>书目名称Bone Drugs in Pediatrics网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0189665<br><br> <br><br>书目名称Bone Drugs in Pediatrics网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0189665<br><br> <br><br>书目名称Bone Drugs in Pediatrics被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0189665<br><br> <br><br>书目名称Bone Drugs in Pediatrics被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0189665<br><br> <br><br>书目名称Bone Drugs in Pediatrics年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0189665<br><br> <br><br>书目名称Bone Drugs in Pediatrics年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0189665<br><br> <br><br>书目名称Bone Drugs in Pediatrics读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0189665<br><br> <br><br>书目名称Bone Drugs in Pediatrics读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0189665<br><br> <br><br>
懦夫
发表于 2025-3-21 22:54:45
Drug Development for Pediatric Diseases with Bone Loss,. We will provide the rationale for developing new anabolic drugs for treatment of bone loss in children. Three different approaches for drug discovery will be described, and new development of bone biology related to drug discovery target will be discussed in detail. Finally, we will talk about dru
人类
发表于 2025-3-22 02:24:18
http://reply.papertrans.cn/19/1897/189665/189665_3.png
树木心
发表于 2025-3-22 05:24:36
ing these drugs in the pediatric population.Highlights the p.Bone Drugs in Pediatrics. brings together in one place the evidence for the use of certain drugs in the treatment and prevention of bone loss in children, as well as the reservations still present in the pediatric community regarding their
indifferent
发表于 2025-3-22 10:22:57
https://doi.org/10.1007/978-3-662-12301-0thyroid hormone-related peptide, and their analogs. We also consider new molecules that are currently under development or of interest, including cathepsin K inhibitors, antisclerostin antibody, and nitric oxide.
FANG
发表于 2025-3-22 15:57:44
http://reply.papertrans.cn/19/1897/189665/189665_6.png
urethritis
发表于 2025-3-22 17:04:10
http://reply.papertrans.cn/19/1897/189665/189665_7.png
引起
发表于 2025-3-22 22:36:24
http://reply.papertrans.cn/19/1897/189665/189665_8.png
Vo2-Max
发表于 2025-3-23 02:00:04
Growth Hormone and Bone,. To improve linear growth and bone mineral metabolism, some recent studies have challenged GH treatment in patients with metabolic bone diseases, in addition to approved diseases. In this chapter, we describe the physiology of GH action, efficacy, and trials of GH treatment. The especially on bone mineral metabolism.
breadth
发表于 2025-3-23 06:09:08
Growth Hormone and Oxandrolone in Burned Children,g post-burn bone health outcomes. The systemic action of these anabolic agents beyond the bone metabolic system has also been explored in the clinical trials described. However, only bone-related markers are discussed in detail in this chapter.